BeOne Medicines AG (BVMF:B1ME34)

BeOne Medicines AG Statistics

Total Valuation

BVMF:B1ME34 has a market cap or net worth of BRL 198.27 billion. The enterprise value is 182.27 billion.

Market Cap	198.27B
Enterprise Value	182.27B

Important Dates

The last earnings date was Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+6.60%
Shares Change (QoQ)	+1.74%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	67.92M

Valuation Ratios

The trailing PE ratio is 542.71 and the forward PE ratio is 75.76.

PE Ratio	542.71
Forward PE	75.76
PS Ratio	7.48
PB Ratio	9.01
P/TBV Ratio	9.15
P/FCF Ratio	68.31
P/OCF Ratio	47.37
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 99.94, with an EV/FCF ratio of 62.80.

EV / Earnings	498.92
EV / Sales	6.91
EV / EBITDA	99.94
EV / EBIT	210.15
EV / FCF	62.80

Financial Position

The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.25.

Current Ratio	2.39
Quick Ratio	2.09
Debt / Equity	0.25
Debt / EBITDA	2.82
Debt / FCF	1.87
Interest Coverage	6.93

Financial Efficiency

Return on equity (ROE) is 1.81% and return on invested capital (ROIC) is 2.36%.

Return on Equity (ROE)	1.81%
Return on Assets (ROA)	1.69%
Return on Invested Capital (ROIC)	2.36%
Return on Capital Employed (ROCE)	3.45%
Revenue Per Employee	2.41M
Profits Per Employee	33,212
Employee Count	11,000
Asset Turnover	0.74
Inventory Turnover	1.43

Taxes

In the past 12 months, BVMF:B1ME34 has paid 606.02 million in taxes.

Income Tax	606.02M
Effective Tax Rate	62.39%

Stock Price Statistics

The stock price has increased by +37.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+37.85%
50-Day Moving Average	60.34
200-Day Moving Average	45.49
Relative Strength Index (RSI)	53.17
Average Volume (20 Days)	144

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.83

Income Statement

In the last 12 months, BVMF:B1ME34 had revenue of BRL 26.50 billion and earned 365.33 million in profits. Earnings per share was 3.12.

Revenue	26.50B
Gross Profit	22.84B
Operating Income	969.23M
Pretax Income	971.35M
Net Income	365.33M
EBITDA	1.75B
EBIT	969.23M
Earnings Per Share (EPS)	3.12

Balance Sheet

The company has 21.51 billion in cash and 5.44 billion in debt, giving a net cash position of 16.08 billion.

Cash & Cash Equivalents	21.51B
Total Debt	5.44B
Net Cash	16.08B
Net Cash Per Share	n/a
Equity (Book Value)	22.01B
Book Value Per Share	198.94
Working Capital	17.57B

Cash Flow

In the last 12 months, operating cash flow was 4.19 billion and capital expenditures -1.28 billion, giving a free cash flow of 2.90 billion.

Operating Cash Flow	4.19B
Capital Expenditures	-1.28B
Free Cash Flow	2.90B
FCF Per Share	n/a

Margins

Gross margin is 86.19%, with operating and profit margins of 3.66% and 1.38%.

Gross Margin	86.19%
Operating Margin	3.66%
Pretax Margin	3.67%
Profit Margin	1.38%
EBITDA Margin	6.60%
EBIT Margin	3.66%
FCF Margin	10.95%

Dividends & Yields

BVMF:B1ME34 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.60%
Shareholder Yield	-6.60%
Earnings Yield	0.18%
FCF Yield	1.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVMF:B1ME34 has an Altman Z-Score of 4.29 and a Piotroski F-Score of 8.

Altman Z-Score	4.29
Piotroski F-Score	8